(Q49148594)

18 February 2018

title

C-reactive protein levels, haplotypes, and the risk of incident chronic obstructive pulmonary disease. (English)

1 reference

18 February 2018

chronic obstructive pulmonary disease

main subject

1 reference

5

Albert Hofman

1 reference

18 February 2018

Jacqueline C M Witteman

6

object named as

Jacqueline C M Witteman

1 reference

18 February 2018

author name string

Yannick M T A van Durme

1

1 reference

18 February 2018

Katia M C Verhamme

2

1 reference

18 February 2018

Albert-Jan L H J Aarnoudse

3

1 reference

18 February 2018

Geert R Van Pottelberge

4

1 reference

18 February 2018

Guy F Joos

7

1 reference

18 February 2018

Guy G Brusselle

8

1 reference

18 February 2018

Bruno H C Stricker

9

1 reference

18 February 2018

language of work or name

English

0 references

publication date

18 December 2008

1 reference

18 February 2018

American Journal of Respiratory and Critical Care Medicine

published in

1 reference

18 February 2018

volume

179

1 reference

18 February 2018

issue

5

1 reference

18 February 2018

page(s)

375-382

1 reference

18 February 2018

Alternative projections of mortality and disability by cause 1990-2020: Global Burden of Disease Study

cites work

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Global burden of COPD: risk factors, prevalence, and future trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Burden and clinical features of chronic obstructive pulmonary disease (COPD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Developing COPD: a 25 year follow up study of the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Systemic effects of chronic obstructive pulmonary disease: what we know and what we don't know (but should).

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Local and systemic inflammation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Mortality in COPD: Role of comorbidities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Pentraxins as a key component of innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Expression of C-reactive protein in the human respiratory tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Genetic determinants of C-reactive protein in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Genetic variation, C-reactive protein levels, and incidence of diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Polymorphism in the human C-reactive protein (CRP) gene, plasma concentrations of CRP, and the risk of future arterial thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Genetically elevated C-reactive protein and ischemic vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

The Rotterdam Study: objectives and design update

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

C-reactive protein in patients with COPD, control smokers and non-smokers

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Targeting C-reactive protein for the treatment of cardiovascular disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Systemic inflammation in COPD: is genetic susceptibility a key factor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Science review: Genetic variability in the systemic inflammatory response

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Progress in chronic obstructive pulmonary disease genetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Interpretative strategies for lung function tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Spirometric reference values from a sample of the general U.S. population

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Ten-year cumulative incidence of COPD and risk factors for incident disease in a symptomatic cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

Chronic obstructive pulmonary disease in the older adult: what defines abnormal lung function?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200810-1540OC

10.1164/RCCM.200810-1540OC

21 January 2018

Identifiers

DOI

1 reference

18 February 2018

1 reference

18 February 2018